Keywords
How to Cite
Abstract
The scientific world has recently become more interested in fasting as a possible therapeutic approach for cancer. Fasting and fasting-mimicking diets (FMDs) have shown great potential in controlling cancer progression, treating various cancers, and improving the outcomes of patients receiving anticancer therapy. The review of multiple studies conducted on several trials in this study indicates that fasting might make cancer cells vulnerable, protect normal cells from chemotherapy, and decrease growth signals associated with cancer such as IGF-1. Ongoing research provides hope that fasting protocols can safely be incorporated into a physician guided cancer treatment protocol, although additional human trials are warranted.
References
Raffaghello L. et al. (2010). Fasting and cancer treatment. Cell Cycle.
• Fontana L. et al. (2008). Calorie restriction and IGF-1. Aging Cell.
• Brandhorst S. et al. (2015). Fasting-mimicking diet and cancer markers. Cell Metabolism.
• de Groot S. et al. (2015). Fasting before chemotherapy. BMC Cancer.
• Longo VD, Panda S. (2016). Fasting and health. Cell Metabolism.
This work is licensed under a Creative Commons Attribution 4.0 International License.
